• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    51.28 -0.82 (-1.57%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,436,161
    Open 51.63
    Bid (Size) 51.28 (300)
    Ask (Size) 51.70 (100)
    Prev. Close 52.10
    Today's Range 50.58 - 52.00
    52wk Range 22.28 - 59.55
    Shares Outstanding 394,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? ↗
    These stocks have surged in the double-digits. 
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    News headline image
    3 Mid-Cap Stocks We’re Skeptical Of
    Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
    Via StockStory

    Performance

    YTD
    +66.1%
    +66.1%
    1 Month
    -8.0%
    -8.0%
    3 Month
    +42.9%
    +42.9%
    6 Month
    +83.7%
    +83.7%
    1 Year
    +108.1%
    +108.1%

    More News

    Read More
    News headline image
    Looks Like M&A Week in 3 Different Sectors ↗
    Via The Motley Fool
    News headline image
    You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
    Via ACCESS Newswire
    News headline image
    2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
    Via StockStory
    Topics Stocks
    News headline image
    Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
    Via StockStory
    Topics Government Stocks World Trade
    News headline image
    Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
    Via Finterra
    Topics Initial Public Offering
    News headline image
    Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy Government Stocks
    Stay informed with the top movers within the S&P500 index on Friday. ↗
    Via Chartmill
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗
    Via The Motley Fool
    News headline image
    Global Growth Engine: Strong Trade and Production Fundamentals Propel U.S. Markets to Historic Highs
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Can the "AI Supercycle" Deliver a Fourth Consecutive Double-Digit Year for the S&P 500?
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy
    News headline image
    Moderna Stock is Soaring. Is It Too Late to Buy? ↗
    Via The Motley Fool
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Via Chartmill
    News headline image
    2 Mooning Stocks to Target This Week and 1 We Avoid
    Via StockStory
    News headline image
    Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
    Via MarketMinute
    Topics Artificial Intelligence Initial Public Offering Stocks
    News headline image
    The S&P 500's 3 Best-Performing Stocks so far in 2026 ↗
    Via MarketBeat
    Topics Stocks
    News headline image
    3 Healthcare Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
    Via MarketMinute

    Frequently Asked Questions

    Is Moderna, Inc. - Common Stock publicly traded?
    Yes, Moderna, Inc. - Common Stock is publicly traded.
    What exchange does Moderna, Inc. - Common Stock trade on?
    Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Moderna, Inc. - Common Stock?
    The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
    What is the current price of Moderna, Inc. - Common Stock?
    The current price of Moderna, Inc. - Common Stock is 51.28
    When was Moderna, Inc. - Common Stock last traded?
    The last trade of Moderna, Inc. - Common Stock was at 04/09/26 04:00 PM ET
    What is the market capitalization of Moderna, Inc. - Common Stock?
    The market capitalization of Moderna, Inc. - Common Stock is 20.20B
    How many shares of Moderna, Inc. - Common Stock are outstanding?
    Moderna, Inc. - Common Stock has 20B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.